Loading chat...
WV HB5149
Bill
Status
Introduced
2/3/2026
Primary Sponsor
Kayla Young
Click for details
AI Summary
- Creates a 5-member West Virginia Prescription Drug Affordability Board with members appointed by the Governor, Senate President, House Speaker, Attorney General, and Insurance Commissioner, serving staggered 5-year terms
- Establishes a 26-member Stakeholder Council including representatives from drug manufacturers, insurers, pharmacists, physicians, hospitals, labor unions, and patient advocacy groups to advise the board
- Requires the board to study pharmaceutical pricing systems and submit findings by December 31, 2029, including policy options like upper payment limits, reverse auctions, and bulk purchasing
- Sets thresholds for cost review including brand name drugs with wholesale costs of $30,000+ per year or price increases of $3,000+ in 12 months, and generic drugs with 200%+ price increases
- Creates a Prescription Drug Affordability Fund capped at $2 million annually, funded by fees on manufacturers, pharmacy benefit managers, insurers, and wholesale distributors
Legislative Description
Establishing the West Virginia Prescription Drug Affordability Board
Health
Last Action
To House Health and Human Resources
2/3/2026
Committee Referrals
Health & Human Resources2/3/2026
Full Bill Text
No bill text available